The 20^th Conference on Retroviruses and Opportunistic Infections (CROI) occurs March 3-6, 2013 at the Georgia World Congress Center, Atlanta, Gerogia.

CROI is a scientifically focused meeting of the world’s leading researchers working to understand, prevent, and treat HIV/AIDS and its complications. The goal of CROI is to provide a forum for translating laboratory and clinical research into progress against the AIDS epidemic. Over 4,000 leading researchers and clinicians from around the world convene in a different location each year for the Conference.

The following HNRC presentations (in alphabetical order by title) were accepted at CROI.

1. Letendre S, Vaida F, Wong S, Croteau D, FitzSimons C, Grant I, Ellis R.  Long-term efavirenz use is associated with worse neurocognitive functioning.
2. Letendre S, McClernon D, Deutsch R, Cherner M, Cookson, Crescini M, Grant I, Ellis R.  Low-level HIV RNA declines over time in csf but not in plasma.
3. Ellis R, Vaida F, Letendre S, Haubrich R, Heaton RK, McCutchan JA, Cherner M, Umlauf A, Sacktor N, Clifford DB.  Randomized trial of CNS-penetrating antiretroviral therapy for HIV-associated cognitive impairment.
4. Tilghman MW, Deshpande S, Battacharya J, Ghate M, Marcotte T, Smith D, Mehendale S.  Viral signatures in HIV-1 subtype C tat are associated with neurocognitive impairment in an Indian cohort.

Click Here to view poster if available (if there is link to the left of the publication title).